Luxembourg: Recommended vaccinations
- Subsequent Tdacp-IPV booster every 10 years
- Babies born to a mother infected with hepatitis B will be offered a first dose at birth
- if no history of vaccination
- It is recommended that populations at risk and elderly 65 years of age and over receive a dose of 13-valent pneumococcal conjugate vaccine (PCV13) followed, 8 weeks later, by a dose of 23-valent pneumococcal polysaccharide vaccine (PCV23). In the present state of knowledge, the CSMI recommends a PPV23 recall only in people at risk, who are recalled every 5 years. Children at risk of invasive pneumococcal infection are also affected by this recommendation: in the absence of previous vaccination with PCV13, catch-up is indicated. For mopre informeation: http://www.sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/index.html
- Given the resurgence of measles, all adults born after 1980 who have not received two doses of measles, mumps and rubella vaccines should recall the MMR vaccine
- Females only
- Catch-up on HPV if not yet done (13-18 years)
More information available at:
http://www.sante.public.lu/fr/prevention/vaccination/index.html
-------------------------------------------------------------------------------------------------------------------------
ADDITIONAL COMMENT
All infant vaccinations in Luxembourg are given free of charge. All subsequent adult vaccinations are not free of charge.
MAJOR HISTORICAL CHANGES
1986: The combined MMR vaccine was introduced in the national childhood vaccination schedule and recommended at 15-18 months of age
1994: The second MMR dose was introduced in the national childhood vaccination schedule and recommended at 5-7 years
2008: March 2008. HPV vaccination was introduced in the national childhood vaccination schedule for females aged 12 years with a catch-up programme up to 18 years of age
2018: MenC 2nd dose introduced at 15-16 years; MenB introduced for increased risk groups
Date of last update: 16 Dec 2020
-------------------------------------------------------------------------------------------------------------------------